In vitro and in vivo testing reveals antioxidant and anti-inflammatory benefits of Ficus religiosa extracts, suggesting potential therapeutic applications.
Introduction: Ficus religiosa has traditionally been used for skin ailments, menstrual disorders, infections, and inflammatory conditions. This study aimed to explore its antioxidant capacity, anti-microbial activity, thrombolytic potential, anti-inflammatory effects, and antipyretic activity. Methods: Antioxidant potential of methanolic and n-hexane extracts was assessed through total phenol, flavonoid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), and nitric oxide (NO) scavenging assays. Anti-microbial activity was tested on selected microbes, cytotoxicity on brine shrimp, and anti-inflammatory properties through membrane-stabilizing potential. Analgesic, antidiarrheal and antipyretic effects were evaluated in mice. Results: The methanol extract had higher total flavonoid and antioxidant capacity content than the n-hexane extract. Both extracts showed substantial total phenolic, flavonoid, and antioxidant content. Methanol and n-hexane extracts showed free radical scavenging capacity against DPPH (IC50: 24.524 μg/mL and 319.669 μg/mL) and NO (IC50: 463.45 μg/mL and 69.45 μg/mL). n-Hexane extract exhibited antimicrobial efficacy against all tested pathogens. At 250 µg/disc, there was a 7 mm zone of inhibition against Pseudomonas spp. and Candida albicans and an 8 mm zone of inhibition against Bacillus subtilis, Escherichia coli, and Streptococcus aureus. Methanol extract had greater anti-inflammatory and thrombolytic activity than n-hexane extract. Maximum antidiarrheal activity was shown by methanol extract (83.48% defecation inhibition, P˂0.001), whereas n-hexane extract demonstrated notable peripheral analgesic activity (72.55% writhing inhibition, P˂0.01). Conclusion: The extract of F. religiosa stem bark has significant therapeutic potential, which might be explored to develop natural remedies for inflammation, microbial infections, and oxidative stress-related disorders. Further study is needed to evaluate its isolated bioactive components.
No takes yet. Share an insight, caveat, or question.
Mehnaz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: